These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21784229)

  • 21. World Influenza Congress Europe 2009.
    Silman NJ
    Expert Rev Vaccines; 2010 Mar; 9(3):273-5. PubMed ID: 20218855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
    Prel A; Le Gall-Reculé G; Jestin V
    Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.
    Keitel WA; Treanor JJ; El Sahly HM; Gilbert A; Meyer AL; Patriarca PA; Cox MM
    Vaccine; 2009 Dec; 28(2):379-85. PubMed ID: 19879222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant expression systems for production of hemagglutinin as a vaccine against influenza virus.
    Redkiewicz P; Sirko A; Kamel KA; Góra-Sochacka A
    Acta Biochim Pol; 2014; 61(3):551-60. PubMed ID: 25203219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for controlling future pandemics of influenza.
    Robertson JS; Inglis SC
    Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.
    Crowe BA; Brühl P; Gerencer M; Schwendinger MG; Pilz A; Kistner O; Koelling-Schlebusch K; Aichinger G; Singer J; Zeitlinger M; Müller M; Ehrlich H; Barrett PN
    Vaccine; 2010 Dec; 29(2):166-73. PubMed ID: 21055500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
    Wu Q; Fang L; Wu X; Li B; Luo R; Yu Z; Jin M; Chen H; Xiao S
    Mol Immunol; 2009 Jul; 46(11-12):2210-7. PubMed ID: 19446339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
    Pushko P; Kort T; Nathan M; Pearce MB; Smith G; Tumpey TM
    Vaccine; 2010 Jul; 28(30):4771-6. PubMed ID: 20470801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.
    Chen CY; Liu HJ; Tsai CP; Chung CY; Shih YS; Chang PC; Chiu YT; Hu YC
    Vaccine; 2010 Nov; 28(48):7644-51. PubMed ID: 20883735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S; Weinberger C; Gessner BD
    Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative influenza vaccines made by insect cells.
    Krammer F; Grabherr R
    Trends Mol Med; 2010 Jul; 16(7):313-20. PubMed ID: 20570562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Aug; 7(6):713-9. PubMed ID: 18665769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.